Pfizer · NSE: PFIZER · BSE: 500680
Q3 FY24 results · Oct–Dec 2023
Pfizer reported revenue from operations of ₹539.97 crore (down 13.2% from Q3 FY23) and net profit of ₹129.98 crore (down 13.7% from Q3 FY23) for Q3 FY24 (Oct–Dec 2023), on a standalone basis.
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 539.97 | 621.75 | −13.2% | 575.21 | −6.1% |
| Other income | 35.85 | 27.41 | +30.8% | 36.07 | −0.6% |
| Total income | 575.82 | 649.16 | −11.3% | 611.28 | −5.8% |
| Profit before tax | 175.94 | 200.68 | −12.3% | 200.52 | −12.3% |
| Net profit for the period | 129.98 | 150.66 | −13.7% | 148.96 | −12.7% |
| EPS, basic (₹) | 27.12 | 32.93 | −17.6% | 32.56 | −16.7% |
| Net margin (%) | 24.1 | 24.2 | 25.9 |
Standalone
- Filed with BSE
- 10 Feb 2024, 11:33 IST
- Board meeting
- 09 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE